Effectiveness of combining behavioral treatment with valproic acid for dysphagia caused by palatal myoclonus in patients with stroke: Two case reports

3Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Palatal myoclonus (PM) is a rare disease that may induce dysphagia. Since dysphagia related to PM is unique and is characterized by myoclonic movements of the involved muscles, specific treatments are needed for rehabilitation. However, no study has investigated the treatment effectiveness for this condition. Therefore, the aim of this case report was to describe the benefit of combining behavioral treatment with valproic acid administration in patients with dysphagia triggered by PM. The two cases were treated with combined treatment. The outcomes evaluated by videofluoroscopic swallowing studies before and after the treatment showed significant decreases in myoclonic movements and improved swallowing function. We conclude that the combined treatment was effective against dysphagia related to PM.

Cite

CITATION STYLE

APA

Kim, B. R., Lee, Y., Kim, S. J., Kim, H., Lee, J. W., Lee, S., & Lee, J. (2018). Effectiveness of combining behavioral treatment with valproic acid for dysphagia caused by palatal myoclonus in patients with stroke: Two case reports. Annals of Rehabilitation Medicine, 42(1), 180–183. https://doi.org/10.5535/arm.2018.42.1.180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free